A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2011
12/06/2011	CA2393464C An additive for an animal feed
12/06/2011	CA2387922C Inhibition of cell motility and angiogenesis
12/06/2011	CA2383522C Neurotherapeutic composition and method
12/06/2011	CA2370867C Use of glucose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
12/06/2011	CA2364386C Method for producing interleukin-1 receptor antagonists, a therapeutic activity protein, from body fluids
12/06/2011	CA2361766C Gcsf conjugates
12/06/2011	CA2345379C A method of modulating cell survival and reagents useful for same
12/06/2011	CA2345287C Tgf-beta superfamily mutant members, including morphogenic proteins
12/06/2011	CA2333306C Peptides based on the sequence of human lactoferrin and their use
12/06/2011	CA2328783C Human procalcitonin and the preparation and use thereof
12/06/2011	CA2309954C Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
12/06/2011	CA2305683C Immunogenic peptides from the hpv e7 protein
12/06/2011	CA2304313C Composition and method for enhancing paracellular transport across cell layers
12/06/2011	CA2301333C Prb2/p130 peptide inhibitors of cdk2 kinase activity
12/06/2011	CA2250164C Oncofetal antigen specific t-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10
12/06/2011	CA2202087C Cloning and characterizing of genes associated with long-term memory
12/01/2011	WO2011150418A2 Compositions and methods for treating pathologies
12/01/2011	WO2011150395A2 Nutrient compositions
12/01/2011	WO2011150393A2 Methods for improving maternal and fetal health
12/01/2011	WO2011150299A2 Treatment of myocardial infarction and vascular injury with netrin-1
12/01/2011	WO2011150279A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
12/01/2011	WO2011150264A2 Synthetic nanocarrier combination vaccines
12/01/2011	WO2011150190A2 Hcv inhibitor compounds and methods of use thereof
12/01/2011	WO2011150144A2 Aqueous formulations for coating microneedle arrays
12/01/2011	WO2011150127A2 Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells
12/01/2011	WO2011150110A1 Methods of purifying polypeptides
12/01/2011	WO2011150102A1 Cyclosporin emulsions
12/01/2011	WO2011150094A2 Tumor suppression compositions
12/01/2011	WO2011150082A2 Methods of utilizing the arrestin-2/stam-1 complex as a therapeutic target
12/01/2011	WO2011150073A2 Compositions comprising the nc2 domain of collagen ix and methods of using same
12/01/2011	WO2011150061A1 Insulin-like growth factor 1 receptor binding peptides
12/01/2011	WO2011149964A2 Methods for treating or preventing vascular graft failure
12/01/2011	WO2011149955A2 Therapeutic method and composition
12/01/2011	WO2011149909A2 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
12/01/2011	WO2011149856A1 Inhibitors of hcv ns5a
12/01/2011	WO2011149472A1 Method for preparing an enriched igg composition from plasma
12/01/2011	WO2011149471A1 Method to prevent/treat post-operative induced constipation
12/01/2011	WO2011149356A1 Collagen powder
12/01/2011	WO2011149310A2 Peptide for inhibiting interaction between rankl and rank, and pharmaceutical composition containing same
12/01/2011	WO2011149173A1 Novel anticancer agents comprising peptides with cancer-specific toxicity
12/01/2011	WO2011149108A1 Treated cell for accelerating regeneration of biotissue
12/01/2011	WO2011149099A1 Antigen peptide and use thereof
12/01/2011	WO2011149096A1 Insulin-resistance-improving drug
12/01/2011	WO2011149036A1 Anti-inflammatory drug
12/01/2011	WO2011149016A1 Complex containing thrombolytic enzyme
12/01/2011	WO2011148972A1 Pharmaceutical composition containing biologically active peptide
12/01/2011	WO2011148959A1 Novel cyclic peptide compound, method for producing same, anti-infective agent, antibiotic-containing fraction, antibiotic, method for producing antibiotic, antibiotic-producing microorganism, and antibiotic produced by same
12/01/2011	WO2011148941A1 Sugar responsive gel and medicine administering device
12/01/2011	WO2011148326A1 Virally-inactivated growth factors-containing platelet lysate depleted of pdgf and vegf and preparation method thereof
12/01/2011	WO2011148200A1 Treatment of pain
12/01/2011	WO2011148135A1 Translocation across eukaryotic cell membranes based on oomycete protein sequence motifs
12/01/2011	WO2011148083A1 Peptide for use as a medicament, in particular for the treatment of cancer
12/01/2011	WO2011148041A1 Modified beta-lactamases and methods and uses related thereto
12/01/2011	WO2011147981A2 Neuregulin isoforms, neuregulin polypeptides and uses thereof
12/01/2011	WO2011147980A1 Pharmaceutical composition comprising ave0010 and insulin glargine
12/01/2011	WO2011147960A1 Antimicrobial peptides and peptide derivatives derived from oncopeltus fasciatus
12/01/2011	WO2011147889A1 Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient
12/01/2011	WO2011147320A1 B cell activating factor antagonist and preparation method and use thereof
12/01/2011	WO2011147319A1 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases
12/01/2011	WO2011147253A1 Polypeptides used for preventing and treating diabetes and lipid metabolic disorder
12/01/2011	WO2011147138A1 Targeting fusion protein of interleukin and preparation method and use thereof
12/01/2011	WO2011147057A1 Anti-angiogenic fusion polypeptide, gene and use thereof
12/01/2011	WO2011127344A3 Method to detect and treat infectious or inflammatory diarrhea based on reg1
12/01/2011	WO2011126873A3 Proteases for degrading gluten
12/01/2011	WO2011123697A3 Histamine-releasing factor (hrf), hrf-receptor and methods of modulating inflammation
12/01/2011	WO2011121036A3 Induction/ monitoring of arteriogenesis using sdf1 and pdgfb or inhibition of phd2
12/01/2011	WO2011098998A3 Chemical preparation of polyubiquitin chains
12/01/2011	WO2011090306A3 Liquid formulations for long-acting erythropoietin conjugate
12/01/2011	WO2011090270A3 Composition containing osmotin for preventing and treating neurological disorders
12/01/2011	WO2011087343A3 Composition for treating cancer related to an hpv infection
12/01/2011	WO2011081443A3 Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof
12/01/2011	WO2011063921A8 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors
12/01/2011	WO2011063336A3 Secondary site of antigen stimulation for therapeutic vaccination
12/01/2011	WO2011060069A3 Glycosyl transferase from chinese hamster and related methods
12/01/2011	WO2011058449A3 Ophthalmic preparations based on bdnf (brain-derived neurotrophic factor) and their use
12/01/2011	WO2011049713A3 Stabilized glucagon solutions
12/01/2011	WO2011035335A3 Stabilized liquid and lyophilized adamts13 formulations
12/01/2011	WO2010133609A3 Composition comprising oil drops
12/01/2011	US20110296544 Colon cancer targets and uses thereof
12/01/2011	US20110295225 Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
12/01/2011	US20110294748 Insulin-like growth factor 1 receptor binding peptides
12/01/2011	US20110294747 Pegylated mutated clostridium botulinum toxin
12/01/2011	US20110294746 Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
12/01/2011	US20110294745 Solutions of lipophilic substances, especially medicinal solutions
12/01/2011	US20110294744 Cyclosporin emulsions
12/01/2011	US20110294743 Metastasis-specific peptides and their diagnostic and therapeutic applications
12/01/2011	US20110294742 Degradable clostridial toxins
12/01/2011	US20110294741 Use of compounds in the treatment of tau-induced cytotoxicities
12/01/2011	US20110294740 Treatment of amyloidoses using myelin basic protein and fragments thereof
12/01/2011	US20110294739 Use of the engrailed homeodomain protein as anxiolytic
12/01/2011	US20110294738 Pthr1 receptor compounds
12/01/2011	US20110294737 Terminally-differentiated anucleate platelet progeny generation
12/01/2011	US20110294736 Compounds and methods for the treatment of autoimmune and inflammatory disease
12/01/2011	US20110294735 Mechanism of neuromedin u action and uses thereof
12/01/2011	US20110294733 Modified human thrombopoietin polypeptide fragment and manufacturing method thereof
12/01/2011	US20110294732 Erythropoletin complementation or replacement
12/01/2011	US20110294731 Skin cream
12/01/2011	US20110294730 Method of treating glaucoma and intraocular hypertension
12/01/2011	US20110294729 Novel Insulin Analogues
12/01/2011	US20110294728 Antiviral Polypeptides

1 ... 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 ... 3163